Literatur
- 1
Höffken G, Lorenz J, Kern W. et al .
S3-guideline on ambulant acquired pneumonia and deep airway infections.
Pneumologie.
2005;
59
612-664
- 2
Metlay J P, Schulz R, Li Y H. et al .
Clinical prediction rule for pulmonary infiltrates.
Ann Intern Med.
1990;
113
664-670
- 3
Young M, Marrie T J.
Interobserver variability in the interpretation of chest roentgenograms of patients
with possible pneumonia.
Arch Intern Med.
1994;
154
2729-2732
- 4
Kauppinen M T, Lahde S, Syrjala H.
Roentgenographic findings of pneumonia caused by Chlamydia pneumoniae. A comparison
with streptococcus pneumonia.
Arch Intern Med.
1996;
156
1851-1856
- 5
Garcia-Ordonez M A, Garcia-Jimenez J M. et al .
Clinical aspects and prognostic factors in elderly patients hospitalised for community-acquired
pneumonia.
Eur J Clin Microbiol Infect Dis.
2001;
20
14-19
- 6
Woodhead M A, Macfarlane J T, McCracken J S. et al .
Prospective study of the aetiology and outcome of pneumonia in the community.
Lancet.
1987;
1
671-674
- 7
Syrjala H, Broas M, Suramo I. et al .
High-resolution computed tomography for the diagnosis of community-acquired pneumonia.
Clin Infect Dis.
1998;
27
358-363
- 8
Fine M J, Smith M A, Carson C A. et al .
Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis.
JAMA.
1996;
275
134-141
- 9
Almirall J, Bolibar I, Toran P. et al .
Contribution of C-reactive protein to the diagnosis and assessment of severity of
community-acquired pneumonia.
Chest.
2004;
125
1335-1342
- 10
Hopstaken R M, Muris J W, Knottnerus J A. et al .
Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein
to a diagnosis of pneumonia in acute lower respiratory tract infection.
Br J Gen Pract.
2003;
53
358-364
- 11
Hansson L O, Hedlund J U, Ortqvist A B.
Sequential changes of inflammatory and nutritional markers in patients with community-acquired
pneumonia.
Scand J Clin Lab Invest.
1997;
57
111-118
- 12
Castro-Guardiola A, Armengou-Arxe A, Viejo-Rodriguez A. et al .
Differential diagnosis between community-acquired pneumonia and non-pneumonia diseases
of the chest in the emergency ward.
Eur J Intern Med.
2000;
11
334-339
- 13
Garcia Vazquez E, Martinez J A, Mensa J. et al .
C-reactive protein levels in community-acquired pneumonia.
Eur Respir J.
2003;
21
702-705
- 14
Seppa Y, Bloigu A, Honkanen P O. et al .
Severity assessment of lower respiratory tract infection in elderly patients in primary
care.
Arch Intern Med.
2001;
161
2709-2713
- 15
Muller C A, Uhl W, Printzen G. et al .
Role of procalcitonin and granulocyte colony stimulating factor in the early prediction
of infected necrosis in severe acute pancreatitis.
Gut.
2000;
46
233-238
- 16
Christ-Crain M, Jaccard-Stolz D, Bingisser R. et al .
Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory
tract infections: cluster-randomised, single-blinded intervention trial.
Lancet.
2004;
363
600-607
- 17
Dalhoff K, Ewig S, Höffken G. et al .
Recommendations for the diagnosis, therapy and prevention of pneumonia in the immunocompromised
host.
Pneumologie.
2002;
56
807-831
- 18
Reed W W, Byrd G S, Gates Jr R H. et al .
Sputum gram's stain in community-acquired pneumococcal pneumonia. A meta-analysis.
West J Med.
1996;
165
197-204
- 19
Bartlett J G.
Decline in microbial studies for patients with pulmonary infections.
Clin Infect Dis.
2004;
39
170-172
- 20
Theerthakarai R, El-Halees W, Ismail M. et al .
Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired
pneumonia.
Chest.
2001;
119
181-184
- 21
Garcia-Vazquez E, Marcos M A, Mensa J. et al .
Assessment of the usefulness of sputum culture for diagnosis of community-acquired
pneumonia using the PORT predictive scoring system.
Arch Intern Med.
2004;
164
1807-1811
- 22
Roson B, Carratala J, Verdaguer R. et al .
Prospective study of the usefulness of sputum Gram stain in the initial approach to
community-acquired pneumonia requiring hospitalization.
Clin Infect Dis.
2000;
31
869-874
- 23
Waterer G W, Wunderink R G.
The influence of the severity of community-acquired pneumonia on the usefulness of
blood cultures.
Respir Med.
2001;
95
78-82
- 24
Corbo J, Friedman B, Bijur P. et al .
Limited usefulness of initial blood cultures in community acquired pneumonia.
Emerg Med J.
2004;
21
446-448
- 25
Roson B, Fernandez-Sabe N, Carratala J. et al .
Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal
pneumonia.
Clin Infect Dis.
2004;
38
222-226
- 26
Gutierrez F, Masia M, Rodriguez J C. et al .
Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus
pneumoniae urinary antigen in a prospective study of community-acquired pneumonia
in Spain.
Clin Infect Dis.
2003;
36
286-292
- 27
Murdoch D R, Laing R T, Cook J M.
The NOW S. pneumoniae urinary antigen test positivity rate 6 weeks after pneumonia
onset and among patients with COPD.
Clin Infect Dis.
2003;
37
153-154
- 28
Helbig J H, Uldum S A, Bernander S. et al .
Clinical utility of urinary antigen detection for diagnosis of community-acquired,
travel-associated, and nosocomial legionnaires' disease.
J Clin Microbiol.
2003;
41
838-840
- 29
Lim W S, Macfarlane J T, Boswell T C. et al .
Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital:
implications for management guidelines.
Thorax.
2001;
56
296-301
- 30
Lindsay D S, Abraham W H, Findlay W. et al .
Laboratory diagnosis of legionnaires' disease due to Legionella pneumophila serogroup
1: comparison of phenotypic and genotypic methods.
J Med Microbiol.
2004;
53
183-187
- 31
Beersma M F, Dirven K, Dam A P van. et al .
Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma
pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the
“gold standard”.
J Clin Microbiol.
2005;
43
2277-2285
- 32
Templeton K E, Scheltinga S A, Graffelman A W. et al .
Comparison and evaluation of real-time PCR, real-time nucleic acid sequence-based
amplification, conventional PCR, and serology for diagnosis of Mycoplasma pneumoniae.
J Clin Microbiol.
2003;
41
4366-4371
Bernhard Schaaf
Medizinische Klinik III, Universitätsklinikum Schleswig-Holstein (UKSH), Campus Lübeck
Ratzeburger Allee 160
23538 Lübeck
Email: schaaf@uni-luebeck.de
